Article
Practical adoption of state-of-the-art hiPSC-cardiomyocyte differentiation techniques.
PloS one - 1 Jan 2020
Rupert Cassady E, Irofuala Chinedu, Coulombe Kareen L K
Abstract excerpt
Human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes are a valuable resource for cardiac therapeutic development; however, generation of these cells in large numbers and high purity is a limitation in widespread adoption. Here, design of experiments (DOE) is used to investigate the cardiac differentiation space of three hiPSC lines when varying CHIR99027 concentration and cell seeding density, and a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
